2898 — Sunho Biologics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMid Cap
- HK$7.62bn
- HK$7.60bn
- CNY56.13m
Annual cashflow statement for Sunho Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -52 | -133 | -80 |
| Depreciation | |||
| Non-Cash Items | 7.01 | 76.9 | -16.4 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 1.58 | 6.47 | -22 |
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Cash from Operating Activities | -34.6 | -40.7 | -109 |
| Capital Expenditures | -1.44 | -1.03 | -49.3 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 0.077 | -82.9 | -296 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -1.36 | -83.9 | -345 |
| Financing Cash Flow Items | -0.456 | -3.48 | -25.6 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 27.1 | 255 | 407 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -8.84 | 123 | -46.1 |